These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11937056)

  • 1. Grafting segments from the extracellular surface of CCR5 onto a bacteriorhodopsin transmembrane scaffold confers HIV-1 coreceptor activity.
    Abdulaev NG; Strassmaier TT; Ngo T; Chen R; Luecke H; Oprian DD; Ridge KD
    Structure; 2002 Apr; 10(4):515-25. PubMed ID: 11937056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses.
    Kuhmann SE; Platt EJ; Kozak SL; Kabat D
    J Virol; 1997 Nov; 71(11):8642-56. PubMed ID: 9343222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines.
    Atchison RE; Gosling J; Monteclaro FS; Franci C; Digilio L; Charo IF; Goldsmith MA
    Science; 1996 Dec; 274(5294):1924-6. PubMed ID: 8943208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion.
    Picard L; Simmons G; Power CA; Meyer A; Weiss RA; Clapham PR
    J Virol; 1997 Jul; 71(7):5003-11. PubMed ID: 9188565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CC chemokine receptor 5-mediated signaling and HIV-1 Co-receptor activity share common structural determinants. Critical residues in the third extracellular loop support HIV-1 fusion.
    Alkhatib G; Ahuja SS; Light D; Mummidi S; Berger EA; Ahuja SK
    J Biol Chem; 1997 Aug; 272(32):19771-6. PubMed ID: 9242636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains.
    Lu Z; Berson JF; Chen Y; Turner JD; Zhang T; Sharron M; Jenks MH; Wang Z; Kim J; Rucker J; Hoxie JA; Peiper SC; Doms RW
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6426-31. PubMed ID: 9177234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1.
    Doranz BJ; Lu ZH; Rucker J; Zhang TY; Sharron M; Cen YH; Wang ZX; Guo HH; Du JG; Accavitti MA; Doms RW; Peiper SC
    J Virol; 1997 Sep; 71(9):6305-14. PubMed ID: 9261347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human chemokine receptors CCR5, CCR3 and CCR2B share common polarity motif in the first extracellular loop with other human G-protein coupled receptors implications for HIV-1 coreceptor function.
    Efremov R; Truong MJ; Darcissac EC; Zeng J; Grau O; Vergoten G; Debard C; Capron A; Bahr GM
    Eur J Biochem; 1999 Aug; 263(3):746-56. PubMed ID: 10469138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage-tropic human immunodeficiency virus type 1 isolates.
    Ross TM; Bieniasz PD; Cullen BR
    J Virol; 1998 Mar; 72(3):1918-24. PubMed ID: 9499044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5 HIV-1 coreceptor activity. Role of cooperativity between residues in N-terminal extracellular and intracellular domains.
    Wang Z; Lee B; Murray JL; Bonneau F; Sun Y; Schweickart V; Zhang T; Peiper SC
    J Biol Chem; 1999 Oct; 274(40):28413-9. PubMed ID: 10497202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity.
    Rucker J; Samson M; Doranz BJ; Libert F; Berson JF; Yi Y; Smyth RJ; Collman RG; Broder CC; Vassart G; Doms RW; Parmentier M
    Cell; 1996 Nov; 87(3):437-46. PubMed ID: 8898197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
    Martín J; LaBranche CC; González-Scarano F
    J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region.
    Platt EJ; Kuhmann SE; Rose PP; Kabat D
    J Virol; 2001 Dec; 75(24):12266-78. PubMed ID: 11711617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives.
    Utaipat U; Duerr A; Rudolph DL; Yang C; Butera ST; Lupo D; Pisell T; Tangmunkongvorakul A; Kamtorn N; Nantachit N; Nagachinta T; Suriyanon V; Robison V; Nelson KE; Sittisombut N; Lal RB
    AIDS Res Hum Retroviruses; 2002 Jan; 18(1):1-11. PubMed ID: 11804551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR5-Mediated human immunodeficiency virus entry depends on an amino-terminal gp120-binding site and on the conformational integrity of all four extracellular domains.
    Genoud S; Kajumo F; Guo Y; Thompson D; Dragic T
    J Virol; 1999 Feb; 73(2):1645-8. PubMed ID: 9882373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop.
    Ross TM; Cullen BR
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7682-6. PubMed ID: 9636210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV and SIV gp120 binding does not predict coreceptor function.
    Baik SS; Doms RW; Doranz BJ
    Virology; 1999 Jul; 259(2):267-73. PubMed ID: 10388651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.
    Laakso MM; Lee FH; Haggarty B; Agrawal C; Nolan KM; Biscone M; Romano J; Jordan AP; Leslie GJ; Meissner EG; Su L; Hoxie JA; Doms RW
    PLoS Pathog; 2007 Aug; 3(8):e117. PubMed ID: 17722977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short communication: identification of the conformational requirement for the specificities of coreceptors for human and simian immunodeficiency viruses.
    Shimizu N; Tanaka A; Jinno-Oue A; Mori T; Ohtsuki T; Hoshino H
    AIDS Res Hum Retroviruses; 2010 Mar; 26(3):321-8. PubMed ID: 20334567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.